Market News & Trends
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated With Atebimetinib + mGnP
Immuneering Corporation recently announced positive updated survival and safety data from its ongoing Phase 2a trial of atebimetinib (IMM-1-104) in combination with modified gemcitabine/nab-paclitaxel (mGnP)…
Arecor Announces Co-Development Agreement With US Insulin Pump Device Company
Arecor Therapeutics plc has recently signed a co-development agreement with Sequel Med Tech LLC, a company developing state-of-the-art insulin delivery technologies, to combine AT278 (500U/mL)…
Hovione & Microinnova Partner to Advance Modular Flow Chemistry for Multi-Purpose Manufacturing
Hovione recently announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. The companies will work together to test Microinnova’s…
Mstack Launches Chemstack AI - A Revolutionary AI-led R&D Platform
As rising tariffs and shifting geopolitical dynamics drive unprecedented demand for domestic chemical supply chains, a fundamental bottleneck has emerged: the specialized process chemistry knowledge…
eXmoor Pharma & Siam Bioscience Form Strategic Partnership to Establish Leading Cell & Gene Therapy Services
eXmoor Pharma and Siam Bioscience recently announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing.…
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
Yatiri Bio Inc. recently announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how…
Nanexa Receives Japanese Patent Approval for Specific PharmaShell Structure
Nanexa recently announced a key patent application has been granted in Japan and has been given the patent number JP7733651B2. The patented invention concerns a…
Abzena Enhances AbZelectPRO Cell Line Offering With New GS Knockout Platforms
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO cell line development (CLD) platform with the launch…
Evonik Launches MaxiPure Polysorbate 80 for Injectable Drug Formulations
Evonik has launched MaxiPure Polysorbate 80 – a highly pure surfactant designed for injectable and biopharmaceutical applications. Engineered to meet the stringent demands of modern…
Kensana Health Lands $120 Million From GEM, Fueling a Global Plant Based Medicine Revolution
Kensana Health Inc. recently announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS, a…
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL for the Treatment of Hypercholesterolemia
Esperion recently announced Otsuka Pharmaceutical Co., Ltd., the Company’s partner for the development and commercialization of NEXLETOL (bempedoic acid) tablets in Japan, has received approval…
Alvotech Announces Marketing Approval of Three New Biosimilars
Alvotech recently announced its commercialization partner in Japan, Fuji Pharma Co., Ltd., has received marketing approval for three new biosimilars from the Japanese Ministry of…
Deciphera Receives European Commission Approval of ROMVIMZA for the Treatment of Tenosynovial Giant Cell Tumor
Ono Pharmaceutical Co., Ltd. recently announced the European Commission (EC) has approved ROMVIMZA (vimseltinib) in the European Union (EU) for the treatment of adult patients…
Kindeva Opens New UK HQ & Manufacturing Site for the Development of Next-Generation Propellants
Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The…
CPHI Frankfurt Pharma Awards 2025 Finalists Announced
Hundreds of entries received across 14 categories showcasing innovation, sustainability, and leadership in pharma Informa Markets, recently announced the shortlist for the CPHI Pharma Awards…
Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study of LP-10 in Oral Lichen Planus
Lipella Pharmaceuticals Inc. recently announced positive final results from its completed Phase 2a multicenter, dose-ranging study evaluating LP-10, a proprietary liposomal tacrolimus oral rinse, in…
Cellares Selects Five Best-in-Class Technology Providers to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), recently announced multiple strategic technology partnerships to advance the Cell Q, the first fully automated quality…
Gerresheimer Expands Collaboration With Portal Instruments for Commercialization of the PRIME Nexus Reusable Autoinjector
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries today announced that it will further expand…
Amphista Therapeutics Discloses First Details of SMARCA2 Degrader Program
Amphista Therapeutics recently disclosed first data on its SMARCA2 program including demonstrating exquisite selectivity of its sequentially bifunctional Targeted Glues for SMARCA2 over the closely…
Roivant & Priovant Announce Positive Phase 3 Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis
Roivant and Priovant Therapeutics recently announced positive results from the Phase 3 VALOR study evaluating brepocitinib in dermatomyositis (DM). On the primary endpoint, brepocitinib 30…
